Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

AC Immune SA

NASDAQ: ACIUHealthcare / Biotechnology / Switzerland
4.73+0.0100+0.21%Vol 194 8201Y Perf -52.79%
Apr 18th, 2019 16:00
BID4.51 ASK4.99
Open4.73 Previous Close4.72
Pre-Market- After-Trading-
 - -%  - -%
Target Price
12.00 
Analyst Rating
Strong Buy 1.50
Potencial %
153.70 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★★ —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★     45.49
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)320 
Earnings Rating
Neutral
Price Range Ratio 52wk %
10.46 
Earnings Date
1st May 2019

Today's Price Range

4.574.79

 

52wk Range

3.2517.40

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
4.19%
3 Months
-58.29%
6 Months
-50.93%
1 Year
-52.79%
3 Years
-
5 Years
-

Name / TickerPriceChg.Chg.%
ACIU4.730.01000.21
AAPL203.860.73000.36
GOOG1 236.370.03000.00
MSFT123.371.60001.31
XOM81.13-0.3000-0.37
WFC47.580.03000.06
JNJ137.52-1.0000-0.72
FB178.28-0.5000-0.28
GE9.350.23002.52
JPM113.46-0.8400-0.73
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
14.60
Current Ratio
14.70
Long Term Debt to Total Capital
0.00
Total Debt to Equity
0.00
Interest Coverage
-170.00
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-704.10
EBITDA Margin
-690.70
Pre-tax Profit Margin
-223.90
Profit Margin
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
5 785
Revenue per Share
0.09
Revenue Growth 3 Years
-40.43
Revenue Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q04 20180.55-0.22-140.00
Q03 2018-0.27-0.1929.63
Q02 2018-0.23-0.2013.04
Q01 2018-0.23-0.2013.04
Q04 2017-0.06-
Q03 2017-0.20-0.1620.00
Q02 2017-0.07-0.22-214.29
Q01 2017-0.17-0.170.00
Earnings Per EndEstimateRevision %Trend
3/2019 QR1.33314.52Positive
6/2019 QR-0.1088.37Positive
12/2019 FY0.75--
12/2020 FY-0.79--
Next Report Date1st May 2019
Estimated EPS Next Report1.33
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume194 820
Shares Outstanding (in ths.)67 562
Trades Count943
Dollar Volume822 724
Avg. Volume587 515
Avg. Weekly Volume578 323
Avg. Monthly Volume403 796
Avg. Quarterly Volume668 691

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

61%39%

Bearish Bullish

68%32%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
1 (25.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.00

There are no comments yet.

News